Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Financials
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 94 860132 331131 461181 758--
Entreprise Value (EV)2 109 142144 340143 328206 008201 497195 280
P/E ratio 44,0x97,9x41,0x32,8x21,8x17,6x
Yield 3,74%2,78%2,80%2,40%2,49%2,61%
Capitalization / Revenue 4,29x5,43x4,94x5,13x4,26x3,91x
EV / Revenue 4,94x5,92x5,38x5,82x4,72x4,20x
EV / EBITDA 15,3x21,6x17,2x18,6x12,7x10,6x
Price to Book 7,61x10,00x8,41x4,06x4,10x3,65x
Nbr of stocks (in thousands) 1 266 8121 311 9131 312 6601 549 128--
Reference price (USD) 74,9101100117117117
Announcement Date 02/14/201902/14/202002/11/2021---
1 GBP in Million
2 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 22 09024 38426 61735 40142 71046 536
EBITDA1 7 1406 6868 31111 07815 89718 489
Operating profit (EBIT)1 5 6726 4367 34010 33614 77217 246
Operating Margin 25,7%26,4%27,6%29,2%34,6%37,1%
Pre-Tax Profit (EBT)1 1 9931 5483 9166 21410 14112 331
Net income1 2 1551 3353 1965 0068 0979 981
Net margin 9,76%5,47%12,0%14,1%19,0%21,4%
EPS2 1,701,032,443,575,396,68
Dividend per Share2 2,802,802,802,822,923,06
Announcement Date 02/14/201902/14/202002/11/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 6 5787 4107 3208 2209 53910 457
EBITDA1 1 9722 2842 6921 8803 1543 877
Operating profit (EBIT)1 1 7951 8992 5241 8052 7232 949
Operating Margin 27,3%25,6%34,5%22,0%28,5%28,2%
Pre-Tax Profit (EBT) 8531 1671 608764--
Net income1 6481 0121 5615501 3751 706
Net margin 9,85%13,7%21,3%6,69%14,4%16,3%
EPS2 0,490,781,190,420,941,13
Dividend per Share ------
Announcement Date 11/05/202002/11/202104/30/202107/29/2021--
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 14 28212 00911 86724 25019 73913 522
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,00x1,80x1,43x2,19x1,24x0,73x
Free Cash Flow1 1 5751 9903 8385 2899 08611 270
ROE (Net Profit / Equities) 32,0%35,6%36,7%26,4%25,8%27,8%
Shareholders' equity1 6 7423 7528 70418 98831 41135 876
ROA (Net Profit / Asset) 7,07%2,19%4,99%9,06%10,8%11,7%
Assets1 30 48061 01564 05355 24575 02485 602
Book Value Per Share2 9,8410,111,928,928,632,2
Cash Flow per Share2 2,072,283,664,857,979,04
Capex1 1 0439799611 3531 6301 632
Capex / Sales 4,72%4,01%3,61%3,82%3,82%3,51%
Announcement Date 02/14/201902/14/202002/11/2021---
1 USD in Million
2 USD
Key data
Capitalization (GBP) 133 488 365 964
Capitalization (USD) 182 343 718 448
Net sales (USD) 26 617 000 000
Number of employees 76 100
Sales / Employee (USD) 349 763
Free-Float 96,3%
Free-Float capitalization (GBP) 128 611 790 067
Free-Float capitalization (USD) 175 682 366 531
Avg. Exchange 20 sessions (USD) 15 229 608 642
Average Daily Capital Traded 11,41%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA